HomeInsightsDividend

Astec Lifesciences Ltd dividend

Astec Lifesciences Ltd dividend

download
stocks purchased

₹ 0.3 Cr

Volume transacted

stocks purchased

2.2 K

stocks traded

Last Updated time: 21 Jul 10:36 AM

Image

Astec Lifesciences Ltd

NSE: ASTEC

DPS

1.5

Last updated : FY 2024

Key Highlights

    The Dividend per Share of Astec Lifesciences Ltd is ₹ 1.5 as of 2024 .a1#The Dividend Payout of Astec Lifesciences Ltd changed from 8.22 % on March 2019 to -6.26 % on March 2024 . This represents a CAGR of NaN% over 6 years. a1#The Latest Trading Price of Astec Lifesciences Ltd is ₹ 1265 as of 19 Jul 15:30 .a1#The Market Cap of Astec Lifesciences Ltd changed from ₹ 1053 crore on March 2019 to ₹ 2082 crore on March 2024 . This represents a CAGR of 12.04% over 6 years. a1#The Revenue of Astec Lifesciences Ltd changed from ₹ 186.98 crore to ₹ 155.8 crore over 8 quarters. This represents a CAGR of -8.72% a1#The EBITDA of Astec Lifesciences Ltd changed from ₹ 28.16 crore to ₹ 14.76 crore over 8 quarters. This represents a CAGR of -27.60% a1#The Net Pr of Astec Lifesciences Ltd changed from ₹ 11.41 crore to ₹ -0.96 crore over 8 quarters. This represents a CAGR of NaN% a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Share Price Vs Dividend Yield

swot
swot

Company Fundamentals For Astec Lifesciences Ltd

Market Cap

2,481 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

6.7

DTE *

1.3

ROE *

-12.7

ROCE *

-4.2

Dividend Yield *

0.14

DPS *

1.5

Dividend Payout *

-6.26

Ann.Dividend % *

15

* All values are consolidated

Last Updated time: 21 Jul 10:36 AM

* All values are consolidated

Last Updated time: 21 Jul 10:36 AM

×

Historical Dividend Payout of Astec Lifesciences Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Astec Lifesciences Ltd

Period
Mar '198
Mar '206
Mar '215
Mar '223
Mar '2312
Mar '24-6

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Astec Lifesciences Ltd

NSE: ASTEC

PRICE

1265.35

-37.25 (-2.86%)

stock direction

Last updated : 19 Jul 15:30

SWOT Analysis Of Astec Lifesciences Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Historical Market Cap of Astec Lifesciences Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Astec Lifesciences Ltd

Period
Mar '191053
Mar '20783
Mar '211959
Mar '223434
Mar '232710
Mar '242083

* All values are a in crore

×

Historical Revenue of Astec Lifesciences Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Astec Lifesciences Ltd

Period
Jun '22187
Sep '22204
Dec '22121
Mar '23130
Jun '23145
Sep '23112
Dec '2352
Mar '24156

* All values are a in crore

×

Historical EBITDA of Astec Lifesciences Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Astec Lifesciences Ltd

Period
Jun '2228
Sep '2237
Dec '2216
Mar '238
Jun '235
Sep '23-2
Dec '23-17
Mar '2415

* All values are a in crore

×

Historical Net Profit of Astec Lifesciences Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Astec Lifesciences Ltd

Period
Jun '2211
Sep '2218
Dec '221
Mar '23-5
Jun '23-8
Sep '23-13
Dec '23-24
Mar '24-1

* All values are a in crore

About Astec Lifesciences Ltd

About Astec Lifesciences Ltd

    Astec LifeSciences Ltd is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates. They are having manufacturing facilities located at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2). They are exporting their products to East Asia, Europe, Middle East, and USA. The business of the company comprises of the two major segments, namely Agrochemicals and Pharmaceuticals. Under the Agrochemical segment, the company manufactures active ingredients, intermediates and formulations. Active ingredients are sold to crop protection formulators. Intermediates are supplied to technical grade product manufacturers. Formulations are sold in bulk quantities to companies engaged in retail marketing. Under the Pharmaceutical segment, the company carries out manufacturing of intermediates which are supplied to Active Pharma Ingredients (API) manufacturers. Astec LifeSciences Ltd was incorporated on January 25, 1994 as a private limited company with the name Urshila Traders Pvt Ltd. The company was originally promoted by Reena Bagai and Avita Fernandes. Their shareholding was purchased by Ashok Hiremath and Pratap Garud on February 11, 1994. In August 19, 1994, the name of the company was changed from Urshila Traders Pvt Ltd to Astec Chemicals Pvt Ltd. In August 1994, the company started their first manufacturing unit by acquiring a sick unit in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap, a pharmaceutical intermediate. In May 2001, they were awarded ISO 9002 Certification by International Standards Certification Pty Limited, Australia. In February 18, 2002, the company entered into an agreement with Behram Chemicals Pvt Ltd with a view to expand their operations for using and operating their manufacturing facilities located at Mahad in Maharashtra. Behram Chemicals Pvt Ltd was engaged in manufacture of chemicals and pesticides with installed capacity of 130 MT. During the year 2003-04, the company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT. In the year 2004, they acquired a plot of land located at Mahad, Maharashtra. In May 2005, they set up a new manufacturing facility as an Export Oriented Unit (as Unit 2), which is adjacent to Unit 1 with an installed capacity of 1000 MT. With the commissioning of Unit 2, the company's total installed capacity increased to 1500 MT. In March 2006, the name of the company was changed from Astec Chemicals Pvt Ltd to Astec LifeSciences Pvt Ltd. In April 2006, the company was converted into public limited company and the name was changed to Astec LifeSciences Ltd. During the year 2006-07, the company further expanded their total capacities to 2000 MT. In January 2007, they established Astec Europe in Tournai, Belgium. During the year 2007-08, the company increased the production capacity of Agro & Pharma Intermediates by 500 MT to 2500 MT In April 2007, Behram Chemicals Pvt Ltd became the subsidiary of the company by the acquisition of 65.63% equity by the company vide Share Purchase Agreement. During the year 2008-09, the company increased the production capacity of Agro & Pharma Intermediates by 300 MT to 2800 MT. They established a relationship with a major multinational for supply of one of our products into the global supply chain. During the year 2009-10, the company increased the production capacity of Agro & Pharma Intermediates by 350 MT to 3150 MT. They also introduced new measures to improve EHS performance. In December 2009, the company has bagged orders worth Rs 7 crore from Syngenta India and Nufarm, which are amongst the world's top ten largest agrochemical manufacturing companies. In June 2010, the company entered into a long term mutually exclusive confidential contract to supply an herbicide to a multinational agrochemical major. In August 2010, the company acquired land in MIDC Mahad area admeasuring 40000 sq mtrs with a view to set up additional manufacturing facilities on the new site. In August 27, 2010, the company's Chairman & Managing Director, Ashok V Hiremath was awarded Prestigious 'Business Excellence' Award by the 'Indo-Thai Entrepreneurs Summit' Bangkok, Thailand for his outstanding contribution towards progress and development of Indian Economy and Society. The Company incorporated a 100% wholly owned subsidiary, Astec CropCare Pvt. Ltd. to start the business of trading in agrochemicals and pesticides formulations to sell products. It made investments to increase the capacity of its manufacturing facility and to improvc the quality of products in Mahad. Work was started on construction of new 40000 sq m site at Mahad in Apr' 11. During the year 2012-13, the Company has set-up a new subsidiary namely, Comercializadora Agricola Agroastrachem Cia Ltda in Bagota, Columbia. During period 2015-16, Godrej Agrovet Limited acquired 45.29% of the Equity Share Capital of the Company from its ex-Promoters through an off-market transaction on 12th October, 2015 and consequently, the Company became a subsidiary of Godrej Agrovet Limited with effect from 6th November, 2015. Godrej Agrovet Limited got listed on the Stock Exchanges, viz., BSE Limited and National Stock Exchange of India Limited on 16th October, 2017. During Financial Year 2020-21, Company sold off its entire equity stake in Astec Europe Sprl (a 50.10% subsidiary of Company in Belgium, Europe), in terms of a Share Purchase Agreement executed on 31st August 2020. Accordingly, Astec Europe Sprl ceased to be a subsidiary of Company with effect from 1st September, 2020. During the Financial Year 2021-22, Company also commissioned its new herbicide plant and completed first batch of CMO product. It commercialized two new CMO products and a new production process for an enterprise product. In April 2023, Company inaugurated a state-of-the-art Research & Development (R&D) Centre, named 'Adi Godrej Centre for Chemical Research and Development' in Rabale, Maharashtra.

Astec Lifesciences Ltd News Hub

News

Astec Lifesciences to discuss results

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 29 July...

Read more

18 Jul 202416:43

News

Astec Lifesciences to conduct AGM

Astec Lifesciences announced that the Annual General Meeting(AGM) of the company will be h...

Read more

03 May 202417:05

News

Astec Lifesciences to declare Quarterly Result

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 2 May 2...

Read more

25 Apr 202410:30

News

Astec Lifesciences to declare Quarterly Result

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 25 Janu...

Read more

13 Jan 202412:31

News

Astec Lifesciences to discuss results

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 27 Octo...

Read more

11 Oct 202311:59

News

Astec Lifesciences Ltd leads gainers in 'A' group

Hindustan Construction Company Ltd, NLC India Ltd, Ircon International Ltd and Cressanda S...

Read more

09 Aug 202312:00

FAQs for dividends of Astec Lifesciences Ltd

What is the current market price of Astec Lifesciences Ltd Ltd as of July 21, 2024?

The current market price of Astec Lifesciences Ltd Ltd stands at 1265.3 per share.

What dividend did Astec Lifesciences Ltd declare in the last fiscal year?

In the last fiscal year, Astec Lifesciences Ltd declared a dividend totaling ₹0.0.

What is the most recent dividend declared by Astec Lifesciences Ltd?

Astec Lifesciences Ltd recently declared a dividend of 0.0 in the latest quarter

How many times has Astec Lifesciences Ltd declared dividends in the current fiscal year

Astec Lifesciences Ltd has declared dividends 4 times totaling ₹0 in the current fiscal year (FY2023-2024).

How many times did Astec Lifesciences Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Astec Lifesciences Ltd declared dividends 4 times totaling ₹0.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199